Glenmark Pharma Q2 profit falls 56.8%, revenue drops 29.8%
In short
Glenmark Pharmaceuticals reported a weaker Q2FY27, with net profit down 56.8% to ₹263.83 crore and revenue down 29.8% to ₹4,247.32 crore. The Business Standard summary says exceptional items hurt earnings.
What the reporting says
Glenmark Pharmaceuticals’ Q2FY27 net profit fell 56.8% to ₹263.83 crore and revenue declined 29.8% to ₹4,247.32 crore, according to a Business Standard summary. The weaker quarterly performance points to pressure on the company’s profitability and sales for the period.
Why it matters
Glenmark Pharmaceuticals reported a sharp drop in Q2FY27 performance, with net profit down 56.8% to ₹263.83 crore and revenue down 29.8% to ₹4,247.32 crore. The summary attributes the weaker earnings to exceptional items. The results indicate pressure on the company’s quarterly profitability and topline.